Ignite Creation Date:
2024-05-05 @ 7:19 PM
Last Modification Date:
2024-10-26 @ 9:47 AM
Study NCT ID:
NCT00648895
Status:
COMPLETED
Last Update Posted:
2010-09-20
First Post:
2008-03-28
Brief Title:
A Study of the Effect of Nebivolol to Evaluate Its Vasodilatory Effects in Hypertensive Patients
Sponsor:
Forest Laboratories
Organization:
Forest Laboratories
Study Overview
Official Title:
Effect of Nebivolol on Forearm Vasodilation Nitric Oxide Bioavailability and Oxidative Stress in Patients With Stage 12 Hypertension
Status:
COMPLETED
Status Verified Date:
2010-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study is designed to compare the effects of nebivolol 10 20 40mgday with another beta blocker extended-release metoprolol at a range of doses Its purpose is to study the mechanism of action of nebivolol on forearm blood flow nitric oxide availability and other biomarkers
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None